XML 65 R44.htm IDEA: XBRL DOCUMENT v3.24.1
Shareholders' Equity (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 5 Months Ended 12 Months Ended
Jan. 30, 2024
USD ($)
May 11, 2023
USD ($)
$ / shares
shares
Jan. 01, 2023
$ / shares
shares
Sep. 13, 2022
USD ($)
$ / shares
shares
Jun. 06, 2022
shares
May 11, 2022
$ / shares
shares
Apr. 04, 2022
USD ($)
$ / shares
shares
Dec. 20, 2021
$ / shares
shares
Nov. 03, 2020
$ / shares
shares
Oct. 31, 2020
$ / shares
shares
Jan. 22, 2020
$ / shares
shares
Jan. 19, 2020
₪ / shares
shares
May 31, 2023
USD ($)
Mar. 31, 2022
USD ($)
shares
Jan. 31, 2022
USD ($)
Jun. 30, 2021
USD ($)
shares
Oct. 31, 2023
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
Dec. 31, 2021
USD ($)
Jan. 25, 2023
shares
Jan. 19, 2020
$ / shares
Jun. 24, 2018
$ / shares
shares
Shareholders’ Equity [Line Items]                                              
Employees resulting in proceeds (in Dollars) | $                           $ 10   $ 127   $ 10 $ 127      
Aggregate amount (in Dollars) | $             $ 13,587               $ 1,000                
Granted options to purchase             30,266                                
Exercise price | (per share)   $ 6.72         $ 33.44         ₪ 0.01                      
Gross proceeds (in Dollars) | $                         $ 6,000         $ 3,000          
Percentage of number of ordinary shares and warrants             15.00%                                
Warrants to purchase     1,563                 24,431                      
Deducting issuance costs (in Dollars) | $                         $ 5,397                    
Purchase and sale of shares   493,421           3,135                              
Issuance of warrants   493,424                                          
Exercisable   5 years                                          
Concurrent private placement (in Dollars) | $ $ 3,500 $ 3,000                                          
Warrants exercisable shares                                   493,421          
Purchase price per share (in Dollars per share) | $ / shares               $ 49.12                   $ 6.08          
Exceed ordinary shares                                   291,544          
Weighted average volatility                                   70.00%          
Risk free interest rates                                   1.40%          
Dividend yields percentage                                   0.00%          
Weighted average life of the options                                   5 years          
Term warrants     3 years                             5 years 6 months          
Purchase warrants     1,563                                        
Warrants exercise price (in Dollars per share) | $ / shares     $ 20                             $ 0.408          
Warrant exercisable per share (in Dollars per share) | $ / shares     $ 24                                        
Weighted average fair value of options granted per share (in Dollars per share) | $ / shares                                   $ 0.13 $ 0.48        
Unrecognized share-based payment expenses related to nonvested awards (in Dollars) | $                                   $ 302          
Expected to be recognized over the next                                   2 years 9 months          
Recorded an expense (in Dollars) | $                                   $ 5          
Common Stock [Member]                                              
Shareholders’ Equity [Line Items]                                              
Converted ordinary shares             30,266                                
Purchase warrants     6,252                                        
Minimum [Member]                                              
Shareholders’ Equity [Line Items]                                              
Weighted average volatility                                   65.00%          
Risk free interest rates                                   1.83%          
Share price (in Dollars per share) | $ / shares                                   $ 2.4          
Maximum [Member]                                              
Shareholders’ Equity [Line Items]                                              
Weighted average volatility                                   68.00%          
Risk free interest rates                                   3.66%          
Share price (in Dollars per share) | $ / shares                                   $ 8.8          
June 24, 2018 [Member]                                              
Shareholders’ Equity [Line Items]                                              
Purchase ordinary shares                                             23,512
Share issued price per share (in Dollars per share) | $ / shares                                             $ 49.12
Vesting rights                                   These options expire 10 years after their grant date and vest over three years in nine tranches. One third of the options vested upon the first-year anniversary and the reminder vested in eight equal quarterly tranches over a period of two years thereafter.          
Options expire                                   10 years          
Recorded an expense (in Dollars) | $                                       89      
January 22, 2020 [Member]                                              
Shareholders’ Equity [Line Items]                                              
Granted options to purchase                     83,912                        
Exercise price | $ / shares                     $ 49.12                        
Warrants to purchase                     9,322                        
Vesting rights                                   These options expire 10 years after their grant date and vest over three years in nine tranches. One-third of the options vested on September 18, 2020 and the remainder vest in eight equal quarterly tranches over a period of two years thereafter.          
Options expire                                   10 years          
Recorded an expense (in Dollars) | $                                     $ 163 380      
October 2020 [Member]                                              
Shareholders’ Equity [Line Items]                                              
Vesting rights                                   The options vest as follows: (1) options to purchase 17,400 ordinary shares vested in one tranche at the end of 12 months from October 13, 2020; and (2) options to purchase 34,801 ordinary shares will vest in the event that the Company generate a cumulative order backlog (as defined in the option agreement) in the amount of not less than $7,000 by the end of 18 months from October 13, 2020; (3) options to purchase 17,400 ordinary shares will vest in the event that the Company reaches a cumulative order backlog of $15,000 by the end of 24 months from October 13, 2020 (including the first cumulative order backlog); and all subject to him serving as the active Chairman of the Company’s Board at the time of vesting and were subject to an acceleration of 25% of his unvested options (i.e., 17,402) in the event that the Company effectuates an IPO. Accordingly, upon the completion of the IPO on April 4, 2022 (see Note 9B(4)), 17,402 were accelerated and considered fully vested.          
Recorded an expense (in Dollars) | $                                     133 332      
Options to purchase                   69,602                          
Exercise price (in Dollars per share) | $ / shares                   $ 49.12                          
Options shares                                   34,801          
October 2020 [Member] | Minimum [Member]                                              
Shareholders’ Equity [Line Items]                                              
Options expire                                   18 months          
October 2020 [Member] | Maximum [Member]                                              
Shareholders’ Equity [Line Items]                                              
Options expire                                   24 months          
May 11 ,2022 [Member]                                              
Shareholders’ Equity [Line Items]                                              
Vesting rights                                   These options expire 10 years after their grant date and vest over three years in nine tranches. One-third of the options vested on May 11, 2023 and the remainder vest in eight equal quarterly tranches over a period of two years thereafter.          
Options expire                                   10 years          
Recorded an expense (in Dollars) | $                                   $ 96 61        
Options to purchase           15,608                                  
Exercise price (in Dollars per share) | $ / shares           $ 14.8                                  
September 13,2022 [Member]                                              
Shareholders’ Equity [Line Items]                                              
Vesting rights                                   These options expire 10 years after their grant date and vest over three years in nine tranches. One-third of the options vested on September 13, 2023 and the remainder vest in eight equal quarterly tranches over a period of two years thereafter.          
Options expire                                   10 years          
Recorded an expense (in Dollars) | $       $ 51                                      
Options to purchase       31,500                                      
Exercise price (in Dollars per share) | $ / shares       $ 14.8                                      
Outstanding options       46,964                           46,021          
Reduced the exercise price (in Dollars per share) | $ / shares       $ 14.8                                      
Additional fair value (in Dollars) | $       $ 30                                      
Warrant [Member]                                              
Shareholders’ Equity [Line Items]                                              
Exercise price | $ / shares                                           $ 0.003  
Warrants to purchase     1,563                                        
Purchase warrants     1,563                                        
Warrants exercise price (in Dollars per share) | $ / shares     $ 12                                        
Warrant exercisable per share (in Dollars per share) | $ / shares     $ 14                             $ 3.1          
IPO [Member]                                              
Shareholders’ Equity [Line Items]                                              
Issued units             473,405                                
Unit description                                   Each unit included one ordinary share and one warrant to purchase one ordinary share at an exercise price of $33.44 per ordinary share. The warrants are exercisable at any time up to five years after the IPO.          
Over-Allotment Option [Member]                                              
Shareholders’ Equity [Line Items]                                              
Granted options to purchase             71,011                                
Gross proceeds (in Dollars) | $             $ 15,647                                
Private Placement [Member]                                              
Shareholders’ Equity [Line Items]                                              
Gross proceeds (in Dollars) | $                                   $ 5,000          
Aggregate of ordinary share                                   493,421          
Employees [Member]                                              
Shareholders’ Equity [Line Items]                                              
Dividend yields percentage                                   0.00%          
Vesting rights                                   These options expire 10 years after their grant date and vest over three years in nine tranches. One-third of the options vested on November 3, 2021, and the remainder vest in eight equal quarterly tranches over a period of two years thereafter.          
Options expire                                   10 years          
Recorded an expense (in Dollars) | $                                   $ 45 46 62      
Exercise price (in Dollars per share) | $ / shares                 $ 49.12                            
Granted options shares                 13,475                            
Employees [Member] | Common Stock [Member]                                              
Shareholders’ Equity [Line Items]                                              
Purchase ordinary shares                           209   2,591              
Chief Executive Officer [Member]                                              
Shareholders’ Equity [Line Items]                                              
Granted options to purchase                                 68,739            
Share issued price per share (in Dollars per share) | $ / shares                                 $ 14.8            
Vesting rights                                   One-third of the options vested on June 18, 2024 and the remainder vest in eight equal quarterly tranches over a period of two years thereafter.          
Options expire                                 10 years            
Recorded an expense (in Dollars) | $                                   $ 22 20 $ 12      
Options to purchase                   7,700               3,850          
Chief Executive Officer [Member] | October 2020 [Member]                                              
Shareholders’ Equity [Line Items]                                              
Vesting rights                                   (1) options to purchase 3,850 ordinary shares will vest on the condition that the Company generates, no later than October 12, 2022, a cumulative order backlog (as defined in the option agreement) in an amount not less than $10,000; and (2) options to purchase the remaining 3,850 ordinary shares will vest on the condition that the Company generates, no later than October 12, 2024 a cumulative order backlog (as defined above) in an amount not less than $20,000 (including the first cumulative order backlog); and all subject to him serving in his position at the time of vesting.          
Chief Executive Officer [Member] | May 11 ,2022 [Member]                                              
Shareholders’ Equity [Line Items]                                              
Options to purchase           19,510                                  
Officer [Member]                                              
Shareholders’ Equity [Line Items]                                              
Vesting rights                                   vest in twelve equal quarterly tranches over a period of three years          
Options expire       10 years                                      
Recorded an expense (in Dollars) | $                                   $ 12 4        
Options to purchase       12,500                                      
Exercise price (in Dollars per share) | $ / shares       $ 14.8                                      
Officer [Member] | May 11 ,2022 [Member]                                              
Shareholders’ Equity [Line Items]                                              
Options to purchase           68,395                                  
Former Chairman [Member] | May 11 ,2022 [Member]                                              
Shareholders’ Equity [Line Items]                                              
Options to purchase           33,277                                  
Director [Member]                                              
Shareholders’ Equity [Line Items]                                              
Vesting rights                                   Such options will vest one-third following 12 months from the grant date of such options, second one-third following 24 months from the grant date and the balance following 36 months.          
Recorded an expense (in Dollars) | $                                   $ 27 17        
Options to purchase           14,974                                  
Exercise price (in Dollars per share) | $ / shares           $ 14.8                                  
Ordinary shares         4,991                                    
Officers and Employees [Member] | September 13,2022 [Member]                                              
Shareholders’ Equity [Line Items]                                              
Exercise price (in Dollars per share) | $ / shares       $ 49.12                                      
Employees One [Member]                                              
Shareholders’ Equity [Line Items]                                              
Recorded an expense (in Dollars) | $                                   $ 22 $ 10        
Share-Based Payment Arrangement, Option [Member]                                              
Shareholders’ Equity [Line Items]                                              
Weighted average life of the options                                   6 years          
Israel Railways [Member]                                              
Shareholders’ Equity [Line Items]                                              
Common stock issued                                         24,431    
Knorr-Bremse [Member] | Warrant [Member]                                              
Shareholders’ Equity [Line Items]                                              
Warrant exercisable per share (in Dollars per share) | $ / shares                                   $ 6.72          
Chief Executive Officer [Member]                                              
Shareholders’ Equity [Line Items]                                              
Exercise price (in Dollars per share) | $ / shares                   $ 49.12